BILR-355 is a reverse transcriptase inhibitor potentially for the treatment of HIV infection. BILR 355 exhibited a nonlinear pharmacokinetic profile and low exposure after orally bioavailable administration to humans References: Tidjane N, Gaboury L, Couture R. Cellular localisation of the kinin B1R in the pancreas of streptozotocin-treated rat and the anti-diabetic effect of the antagonist SSR240612. Biol Chem. 2016 Apr;397(4):323-36. doi: 10.1515/hsz-2015-0230. PubMed PMID: 26841446.

纯度：≥98%

CAS：380378-81-4